Skip to main content
. 2020 May 24;20:467. doi: 10.1186/s12885-020-06965-4

Fig. 1.

Fig. 1

Representative high-grade serous ovarian cancer showing immunostaining for Drp1 (a), phospho-Drp1Ser637 (b), and CaMKI (c) (upper) and each negative or weak staining (bottom) (magnification, × 200). Scale bar is 50 μm